272 related articles for article (PubMed ID: 33547282)
21. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
Miyauchi J
Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
[TBL] [Abstract][Full Text] [Related]
22. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
Yamazaki J; Jelinek J; Lu Y; Cesaroni M; Madzo J; Neumann F; He R; Taby R; Vasanthakumar A; Macrae T; Ostler KR; Kantarjian HM; Liang S; Estecio MR; Godley LA; Issa JP
Cancer Res; 2015 Jul; 75(14):2833-43. PubMed ID: 25972343
[TBL] [Abstract][Full Text] [Related]
23. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.
Xu G; Kanezaki R; Toki T; Watanabe S; Takahashi Y; Terui K; Kitabayashi I; Ito E
Leukemia; 2006 Jun; 20(6):1002-8. PubMed ID: 16628190
[TBL] [Abstract][Full Text] [Related]
24. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing.
Lim JH; Kang YJ; Lee BY; Han YJ; Chung JH; Kim MY; Kim MH; Kim JW; Cho YH; Ryu HM
Clin Epigenetics; 2019 Dec; 11(1):180. PubMed ID: 31801612
[TBL] [Abstract][Full Text] [Related]
25. Comparative DNA methylation and gene expression analysis identifies novel genes for structural congenital heart diseases.
Grunert M; Dorn C; Cui H; Dunkel I; Schulz K; Schoenhals S; Sun W; Berger F; Chen W; Sperling SR
Cardiovasc Res; 2016 Oct; 112(1):464-77. PubMed ID: 27496870
[TBL] [Abstract][Full Text] [Related]
26. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
27. Meta-Analysis of DNA Methylation Datasets Shows Aberrant DNA Methylation of Thyroid Development or Function Genes in Down Syndrome.
Lauffer P; Zwaveling-Soonawala N; Li S; Bacalini MG; Naumova OY; Wiemels J; Boelen A; Henneman P; de Smith AJ; van Trotsenburg ASP
Thyroid; 2023 Jan; 33(1):53-62. PubMed ID: 36326208
[No Abstract] [Full Text] [Related]
28. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.
Haertle L; Müller T; Lardenoije R; Maierhofer A; Dittrich M; Riemens RJM; Stora S; Roche M; Leber M; Riedel-Heller S; Wagner M; Scherer M; Ravel A; Mircher C; Cieuta-Walti C; Durand S; van de Hove DLA; Hoffmann P; Ramirez A; Haaf T; El Hajj N; Mégarbané A
Clin Epigenetics; 2019 Dec; 11(1):195. PubMed ID: 31843015
[TBL] [Abstract][Full Text] [Related]
29. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
30. Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1.
Tomazou EM; Sheffield NC; Schmidl C; Schuster M; Schönegger A; Datlinger P; Kubicek S; Bock C; Kovar H
Cell Rep; 2015 Feb; 10(7):1082-95. PubMed ID: 25704812
[TBL] [Abstract][Full Text] [Related]
31. A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers.
Marsman J; Thomas A; Osato M; O'Sullivan JM; Horsfield JA
Sci Rep; 2017 Oct; 7(1):13347. PubMed ID: 29042628
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging.
Bocker MT; Hellwig I; Breiling A; Eckstein V; Ho AD; Lyko F
Blood; 2011 May; 117(19):e182-9. PubMed ID: 21427290
[TBL] [Abstract][Full Text] [Related]
33. Increased dosage of the RUNX1/AML1 gene: a third mode of RUNX leukemia?
Osato M; Ito Y
Crit Rev Eukaryot Gene Expr; 2005; 15(3):217-28. PubMed ID: 16390318
[TBL] [Abstract][Full Text] [Related]
34. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.
Stankiewicz MJ; Crispino JD
Blood; 2009 Apr; 113(14):3337-47. PubMed ID: 19168790
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome.
Zhang J; Zhou W; Liu Y; Li N
Mol Med Rep; 2016 Nov; 14(5):4309-4314. PubMed ID: 27667480
[TBL] [Abstract][Full Text] [Related]
36. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
37. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.
Alford KA; Slender A; Vanes L; Li Z; Fisher EM; Nizetic D; Orkin SH; Roberts I; Tybulewicz VL
Blood; 2010 Apr; 115(14):2928-37. PubMed ID: 20154221
[TBL] [Abstract][Full Text] [Related]
38. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.
Kubota Y; Uryu K; Ito T; Seki M; Kawai T; Isobe T; Kumagai T; Toki T; Yoshida K; Suzuki H; Kataoka K; Shiraishi Y; Chiba K; Tanaka H; Ohki K; Kiyokawa N; Kagawa J; Miyano S; Oka A; Hayashi Y; Ogawa S; Terui K; Sato A; Hata K; Ito E; Takita J
Cancer Sci; 2019 Oct; 110(10):3358-3367. PubMed ID: 31385395
[TBL] [Abstract][Full Text] [Related]
39. Haematopoietic development and leukaemia in Down syndrome.
Roberts I; Izraeli S
Br J Haematol; 2014 Dec; 167(5):587-99. PubMed ID: 25155832
[TBL] [Abstract][Full Text] [Related]
40. Epigenome-wide study for the offspring exposed to maternal HBV infection during pregnancy, a pilot study.
Cheng Q; Zhao B; Huang Z; Su Y; Chen B; Yang S; Peng X; Ma Q; Yu X; Zhao B; Ke X
Gene; 2018 Jun; 658():76-85. PubMed ID: 29526602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]